Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs

Journal of Virology

Volumn 77, Issue 12, 2003, Pages 7078-7092

  Hui, Eric Ka Wai ^a   Barman, Subrata ^a   Yang, Tae Yong ^a   Nayak, Debi P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; MATRIX PROTEIN; MUTANT PROTEIN; PROLINE; PROLYLTHREONYLALANYLPROLINE; TYROSYLARGINYLLYSYLLEUCINE; TYROSYLPROLYLASPARTYLLEUCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DELETION MUTANT; HELIX SIX DOMAIN; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; LIFE CYCLE; MOLECULAR CLONING; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RETROVIRUS; REVERTANT; SITE DIRECTED MUTAGENESIS; VIROGENESIS; VIRUS CULTURE; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS PARTICLE; VIRUS REPLICATION; WILD TYPE; YRKL MOTIF;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL NUCLEUS; CYTOPLASM; DOGS; HUMANS; INFLUENZA A VIRUS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR LOCALIZATION SIGNALS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0038618682     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.12.7078-7092.2003     Document Type: Article

References (76)

1. Accola, M. A., B. Strack, and H. G. Göttlinger. 2000. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74:5395-5402.
2. Allen, H., J. McCauley, M. Waterfield, and M. J. Gething. 1980. Influenza virus RNA segment 7 has the coding capacity for two polypeptides. Virology 107:548-551.
3. Arzt, S., F. Baudin, A. Barge, P. Timmins, W. P. Burmeister, and R. W. H. Ruigrok. 2001. Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology. 279:439-446.
4. Barman, S., L. Adhikary, Y. Kawaoka, and D. P. Nayak. 2003. Influenza A virus hemagglutinin containing basolateral localization signal does not alter the apical budding of a recombinant influenza A virus in polarized MDCK cells. Virology 305:138-152.
5. Baudin, F., C. Bacj, S. Cusak, and R. W. H. Ruigrok. 1994. Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J. 13:3158-3165.
6. Baudin, F., I. Petit, W. Weissenhorn, and R. W. H. Ruigrok. 2001. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 281:102-108.
7. Bucher, D. J., I. G. Kharitonenkov, J. A. Zakomirdin, V. B. Grigoriev, S. M. Klimenko, and J. F. Davis. 1980. Incorporation of influenza virus M-protein into liposomes. J. Virol. 36:586-590.
8. Choi, Y. G., G. L. Grantham, and A. L. N. Rao. 2000. Molecular studies on Bromovirus capsid protein. Virology 270:377-385.
9. Cimarelli, A., and J.-L. Darlix. 2002. Assembling the human immunodeficiency virus type 1. Cell. Mol. Life Sci. 59:1166-1184.
10. Craven, R. C., R. N. Harty, J. Paragas, P. Palese, and J. W. Wills. 1999. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J. Virol. 73:3359-3365.
11. Demirov, D. G., J. M. Orenstein, and E. O. Freed. 2002. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J. Virol. 76:105-117.
12. Elster, C., K. Larsen, J. Gagnon, R. W. H. Ruigrok, and F. Baudin. 1997. Influenza virus M1 protein binds to RNA through its nuclear localization signal. J. Gen. Virol. 78:1589-1596.
13. Favoreel, H. W., G. van Minnebruggen, H. J. Nauwynck, L. W. Enquist, and M. B. Pensaert. 2002. A tyrosine-based motif in the cytoplasmic tail of pseudorabies virus glycoproteins B is important for both antibody-induced internalization of viral glycoproteins and efficient cell-to-cell spread. J. Virol. 76:6845-6851.
14. Freed, E. O. 2002. Viral late domain. J. Virol. 76:4679-4687.
15. Garrus, J. E., U. K. von Schwedler, O. W. Pornillos, S. G. Morham, K. H. Zavitz, H. E. Wang, D. A. Wettstein, K. M. Stray, M. Côte, R. L. Rich, D. G. Myszka, and W. I. Sundquist. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65.
16. Gómez-Puertas, P., C. Albo, E. Pérez-Pastrana, A. Vivo, and A. Portela. 2000. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 74:11538-11547.
17. Gregoriades, A., and B. Frangione. 1980. Interaction of influenza M protein with viral lipid and phosphatidylcholine vesicles. J. Virol. 36:470-479.
18. Gregoriades, A., and B. Frangione. 1981. Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. J. Virol. 40:323-328.
19. Gujuluva, C. N., A. Kundu, K. G. Murti, and D. P. Nayak. 1994. Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes. Virology 204:491-505.
20. Harris, A., F. Forouhar, S. Qiu, B. Sha, and M. Luo. 2001. The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1. Virology 289:34-44.
21. Harris, A., B. Sha, and M. Luo. 1999. Structural similarities between influenza virus matrix protein M1 and human immunodeficiency virus matrix and capsid proteins: an evolutionary link between negative-stranded RNA viruses and retroviruses. J. Gen. Virol. 80:863-869.
22. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hohom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97:6108-6113.
23. Huang, X., T. Liu, J. Muller, R. A. Levandowski, and Z. Ye. 2001. Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export. Virology 287:405-416.
24. Hui, E. K.-W., K. L. Chen, and S. J. Lo. 1999. Hepatitis B viral maturation is affected by the incorporation of core proteins having a C-terminal substitution of arginine or lysine stretches. J. Gen. Virol. 80:2661-2671.
25. Hui, E. K.-W., and D. P. Nayak. 2001. Role of ATP in influenza virus budding. Virology 290:329-341.
26. Hui, E. K.-W., and D. P. Nayak. 2002. Role of G protein and protein kinase signaling in influenza virus budding in MDCK cells. J. Gen. Virol. 83:3055-3066.
27. Kuribayashi, H., T. Takahashi, K. Nagata, A. Ueno, and H. Mihara. 2000. Construction of two-stranded α-helix peptides based on influenza virus M1 protein selectively bound to RNA. Bioorg. Med. Chem. Lett. 10:2227-2230.
28. LaCasse, E. C., and Y. A. Lefebvre. 1995. Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Res. 23:1647-1656.
29. Lamb, R. A., and R. M. Krug. 2001. Orthomyxoviridae: the viruses and their replication, p. 725-769. In D. M. Knipe and P. M. Howley (ed.), Fundamental virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, Pa.
30. Latham, T., and J. M. Galarza. 2001. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J. Virol. 75:6154-6165.
31. Le Blanc, I., M.-C. Prévost, M.-C. Dokhélar, and A. R. Rosenberg. 2002. The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process. J. Virol. 76:10024-10029.
32. Lee, S.-K., and D. L. Hacker. 2001. In vitro analysis of an RNA binding site within the N-terminal 30 amino acids of the Southern cowpea mosaic virus core protein. Virology 286:317-327.
33. Liu, T., and Z. Ye. 2002. Restriction of viral replication by mutation of the influenza virus matrix protein. J. Virol. 76:13055-13061.
34. Liu, T., J. Muller, and Z. Ye. 2002. Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology 304:89-96.
35. Lopez-Turiso, J. A., C. Martinez, T. Tanaka, and J. Ortín. 1990. The synthesis of influenza virus negative-strand RNA takes place in insoluble complexes present in the nuclear matrix fraction. Virus Res. 16:325-337.
36. Luban, J. 2001. HIV-1 and Ebola virus: the getaway driver nabbed. Nat. Med. 7:1278-1280.
37. Mora, R., E. Rodiguez-Boulan, P. Palese, and A. Garcia-Sastre. 2002. Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J. Virol. 76:3544-3553.
38. Morrison, K. L., and G. A. Weiss. 2001. Combinatorial alanine-scanning. Curr. Opin. Chem. Biol. 5:302-307.
39. Nassal, M. 1992. The arginine-rich domain of the hepatitis B virus core protein is required for pergenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 66:4107-4116.
40. Nayak, D. P. 2000. Virus morphology, replication and assembly, p. 64-123. In C. J. Hurst (ed.), Viral ecology. Academic Press, New York, N.Y.
41. Nayak, D. P., and E. K.-W. Hui. 2002. Assembly and morphogenesis of influenza viruses. Recent Res. Dev. Virol. 4:35-54.
42. Olson, J. K., and C. Grose. 1997. Endocytosis and recycling of varicellazoster virus Fc receptor glycoproteins gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J. Virol. 71:4042-4054.
43. Parent, L. J., R. P. Bennett, R. C. Craven, T. D. Nelle, N. K. Krishna, J. B. Bowzard, C. B. Wilson, B. A. Puffer, R. C. Montelaro, and J. W. Wills. 1995. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69:5455-5460.
44. Patnaik, A., and J. W. Wills. 2002. In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain. J. Virol. 76:2789-2795.
45. Perez, D. R., and R. O. Donis. 1998. The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. Virology 249:52-61.
46. Perez, O. D., and G. P. Nolan. 2001. Resistance is futile: assimilation of cellular machinery by HIV-1. Immunity 15:687-690.
47. Portela, A., and P. Digard. 2002. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83:723-734.
48. Puffer, B. A., L. J. Parent, J. W. Wills, and R. C. Montelaro. 1997. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71:6541-6546.
49. Puffer, B. A., S. C. Watkins, and R. C. Montelaro. 1998. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly. J. Virol. 72:10218-10221.
50. Rees, P. J., and N. J. Dimmock. 1982. Kinetics of synthesis of influenza virus ribonucleoprotein structures. J. Gen. Virol. 59:403-408.
51. Reinhardt, J., and T. Wolff. 2000. The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet. Microbiol. 74:87-100.
52. Rey, O., and D. P. Nayak. 1992. Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins. J. Virol. 66:5815-5824.
53. Roberts, P. C., and R. W. Compans. 1998. Host cell dependence of viral morphology. Proc. Natl. Acad. Sci. USA 95:5746-5751.
54. Roberts, P. C., R. A. Lamb, and R. W. Compans. 1998. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240:127-137.
55. Ruigrok, R. W. H., A. Barge, P. Durrer, J. Brunner, K. Ma, and G. R. Whittaker. 2000. Membrane interaction of influenza virus M1 protein. Virology 267:289-298.
56. Ruigrok, R. W. H., and F. Baudin. 1995. Structure of influenza virus ribonucleoprotein particles. II. Purified RNA-free influenza virus ribonucleoprotein forms structures that are indistinguishable from the intact influenza virus ribonucleoprotein particles. J. Gen. Virol. 76:1009-1014.
57. Schmitz, I., and A. L. N. Rao. 1998. Deletions in the conserved aminoterminal basic arm of cucumber mosaic virus coat protein disrupt virion assembly but do not abolish infectivity and cell-to-cell movement. Virology 248:323-331.
58. Schulze, I. T. 1972. The structure of influenza virus. II. A model based on the morphology and composition of subviral particles. Virology 47:181-196.
59. Sha, B., and M. Luo. 1997. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4:239-244.
60. Shishkov, A. V., V. I. Goldanskii, L. A. Baratova, N. V. Fedorova, A. L. Ksenofontov, O. P. Zhirnov, and A. V. Galkin. 1999. The in situ spatial arrangement of the influenza A virus matrix protein M1 assessed by tritium bombardment. Proc. Natl. Acad. Sci. USA 96:7827-7830.
61. Tan, R., and A. D. Frankel. 1995. Structural variety of arginine-rich RNA binding peptides. Proc. Natl. Acad. Sci. USA 92:5282-5286.
62. Tirabassi, R. S., and L. W. Enquist. 1999. Mutation of the YXXL endocytosis motif in the cytoplasmic tail of pseudorabies virus gE. J. Virol. 73:2717-2728.
63. van der Graaf, M., R. M. Scheek, C. C. van der Linden, and M. A. Hemminga. 1992. Conformation of a pentacosapeptide representing the RNA-binding N-terminus of cowpea chlorotic mottle virus coat protein in the presence of oligophosphates: a two dimensional proton nuclear magnetic resonance and distance geometry study. Biochemistry 31:9177-9182.
64. Wakefield, L., and G. G. Brownlee. 1989. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:8569-8580.
65. Watanabe, K., H. Handa, K. Mizumoto, and K. Nagata. 1996. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J. Virol. 70:241-247.
66. Whittaker, G., I. Kemler, and A. Helenius. 1995. Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus. J. Virol. 69:439-445.
67. gag late assembly domain. J. Virol. 70:5695-5700.
68. Yasuda, J., S. Nakada, A. Kato, T. Toyoda, and K. Ishihama. 1993. Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology 196:249-255.
69. Ye, Z., N. W. Baylor, and R. R. Wanger. 1989. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 63:3586-3594.
70. Ye, Z., T. Liu, D. P. Offringa, J. McInnis, and R. A. Levandowski. 1999. Association of influenza virus matrix protein with ribonucleoproteins. J. Virol. 73:7467-7473.
71. 1) protein of influenza A virus. J. Virol. 61:239-246.
72. 1) of influenza virus. J. Virol. 69:1964-1970.
73. Yuan, B., S. Campbell, E. Bacharach, A. Rein, and S. P. Goff. 2000. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J. Virol. 74:7250-7260.
74. Zhao, H., M. Ekström, and H. Garoff. 1998. The M1 and NP proteins of influenza A virus form homo- but not heterooligomeric complexes when coexpressed in BHK-21 cells. J. Gen. Virol. 79:2435-2446.
75. Zhirnov, O. P., and H.-D. Klenk. 1997. Histones as a target for influenza virus matrix protein M1. Virology 235:302-310.
76. Zimmer, G., K.-P. Zimmer, I. Trotz, and G. Herrler. 2002. Vesicular stomatitis virus glycoprotein does not determine the site of virus release in polarized epithelial cells. J. Virol. 76:4103-4107.